DiviDrip · APGE

APGE — Apogee Therapeutics, Inc.

APGE is Apogee Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $135.07. Market cap: $10.22B. Capital Quality Rank: 72/100 — Elite compounder.

Stock snapshot

Price$135.07
Market cap$10.22B
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)72 / 100 · Elite compounder
ROIC (TTM)-7.2%
Shareholder buyback yield-9.06%
Altman Z-score zoneSafe

About APGE

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Listed2023Employees261HQSan Francisco, CASectorHealthcareWebsiteapogeetherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside APGE. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is APGE's current stock price?

APGE (Apogee Therapeutics, Inc.) is currently trading at $135.07.

Does APGE pay a dividend?

APGE (Apogee Therapeutics, Inc.) does not currently pay a regular dividend.

What is APGE's Capital Quality Rank?

APGE has a Capital Quality Rank of 72/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track APGE in DiviDrip

Add APGE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow